Jump Financial »

Silence Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2024-06-30 $235k 12k 19.00
2024-03-31 $406k 19k 21.60

More positions owned by Jump Financial

SPDR Dow Jones Industrial Average ETF Trust Etf (DIA)
Invesco QQQ Trust Series 1 Etf (QQQ)
POSCO Holdings Depositary Receipt (PKX)
Vanguard S&P 500 ETF Etf (VOO)
VanEck Semiconductor ETF Etf (SMH)
CME Group Common Stock (CME)
iShares 20 Year Treasury Bond ETF Etf (TLT)
Tesla Common Stock (TSLA)
Intercontinental Exchange Common Stock (ICE)
Technology Select Sector SPDR Fund Etf (XLK)
Microsoft Corp Common Stock (MSFT)
Alphabet Common Stock (GOOGL)
Netflix Common Stock (NFLX)
SPDR S&P 500 ETF Trust Etf Call Option (SPY)
Eli Lilly & Co Common Stock (LLY)

View all positions for Jump Financial

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Logos Global Management
Deep Track Capital
Frazier Life Sciences Management
Nextech Invest
Henderson Group
Eventide Asset Management
Cormorant Asset Management
Ikarian Capital
5AM Venture Management
Point72 Asset Management
Citadel Advisors
Woodline Partners

View all funds holding Silence Therapeutics